[DDAVP: biological effect and clinical utility].
Zuazu-Jausoro
I
I
Unidad de Hematología, Hospital General Universitario de Murcia.
Vicente
V
V
Oliver
A
A
Fontcuberta
J
J
D000368:Aged; D001778:Blood Coagulation Disorders / Q000188:drug therapy; D001779:Blood Coagulation Factors / Q000378:metabolism; D002315:Cardiopulmonary Bypass; D003894:Deamino Arginine Vasopressin / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D006474:Hemorrhagic Disorders / Q000097:blood / Q000188:drug therapy*; D006487:Hemostasis / Q000187:drug effects; D006801:Humans; D008297:Male; D010973:Platelet Adhesiveness / Q000187:drug effects; D011183:Postoperative Complications / Q000517:prevention & control; D015398:Signal Transduction; D013927:Thrombosis / Q000139:chemically induced
D001779:Blood Coagulation Factors; D003894:Deamino Arginine Vasopressin
DDAVP: efecto biológico y utilidad clínica.